These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

581 related items for PubMed ID: 9552449

  • 1. The effect of operating and formulation variables on the morphology of spray-dried protein particles.
    Maa YF, Costantino HR, Nguyen PA, Hsu CC.
    Pharm Dev Technol; 1997 Aug; 2(3):213-23. PubMed ID: 9552449
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Spray-drying performance of a bench-top spray dryer for protein aerosol powder preparation.
    Maa YF, Nguyen PA, Sit K, Hsu CC.
    Biotechnol Bioeng; 1998 Nov 05; 60(3):301-9. PubMed ID: 10099432
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Particle size dependence of polymorphism in spray-dried mannitol.
    Lee YY, Wu JX, Yang M, Young PM, van den Berg F, Rantanen J.
    Eur J Pharm Sci; 2011 Sep 18; 44(1-2):41-8. PubMed ID: 21699976
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of carrier morphology and surface characteristics on the development of respirable PLGA microcapsules for sustained-release pulmonary delivery of insulin.
    Hamishehkar H, Emami J, Najafabadi AR, Gilani K, Minaiyan M, Mahdavi H, Nokhodchi A.
    Int J Pharm; 2010 Apr 15; 389(1-2):74-85. PubMed ID: 20085803
    [Abstract] [Full Text] [Related]

  • 9. Nano spray drying: a novel method for preparing protein nanoparticles for protein therapy.
    Lee SH, Heng D, Ng WK, Chan HK, Tan RB.
    Int J Pharm; 2011 Jan 17; 403(1-2):192-200. PubMed ID: 20951781
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Co-spray-dried mannitol-ciprofloxacin dry powder inhaler formulation for cystic fibrosis and chronic obstructive pulmonary disease.
    Adi H, Young PM, Chan HK, Agus H, Traini D.
    Eur J Pharm Sci; 2010 Jun 14; 40(3):239-47. PubMed ID: 20371286
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Development and testing of particulate formulations for the nasal delivery of antibodies.
    Kaye RS, Purewal TS, Alpar OH.
    J Control Release; 2009 Apr 17; 135(2):127-35. PubMed ID: 19059291
    [Abstract] [Full Text] [Related]

  • 14. L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders.
    Li L, Sun S, Parumasivam T, Denman JA, Gengenbach T, Tang P, Mao S, Chan HK.
    Eur J Pharm Biopharm; 2016 May 17; 102():132-41. PubMed ID: 26970252
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Physicochemical and in vitro deposition properties of salbutamol sulphate/ipratropium bromide and salbutamol sulphate/excipient spray dried mixtures for use in dry powder inhalers.
    Corrigan DO, Corrigan OI, Healy AM.
    Int J Pharm; 2006 Sep 28; 322(1-2):22-30. PubMed ID: 16815654
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Process characteristics and compaction of spray-dried emulsions containing a drug dissolved in lipid.
    Hansen T, Holm P, Schultz K.
    Int J Pharm; 2004 Dec 09; 287(1-2):55-66. PubMed ID: 15541912
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.